We are live on ! Find out more
KALA icon

KALA BIO

36 hedge funds and large institutions have $33.7M invested in KALA BIO in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.67% less ownership

Funds ownership: 38.91% → 37.23% (-1.7%)

8% less funds holding

Funds holding: 39 → 36 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

43% less capital inflows, than outflows

Capital inflows: $2.12M | Capital outflows: $3.7M

54% less call options, than puts

Call options by funds: $79K | Put options by funds: $172K

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
9
Closed
10
Calls
$79K
Puts
$172K
Net Calls
-$93K
Net Calls Change
-$16K

KALA Hedge Fund Activity: Q1 2022 in Review

36 of the 6,365 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2022, worth a combined $33.7M — up 9.1% from $30.9M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of KALA and 7 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 3 added.

The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $708K. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $776K sold.

  • 36 institutional investors held KALA BIO (KALA) as of Q1 2022, down from 39 in Q4 2021.
  • Funds reported $33.7M of KALA BIO stock for Q1 2022, up 9.1% quarter-over-quarter.
  • 7 funds opened new KALA BIO positions in Q1 2022 and 10 closed out, a net change of -3 holders.
  • The largest KALA BIO buyer in Q1 2022 was Board of Trustees of The Leland Stanford Junior University, an estimated $708K added.
  • The largest KALA BIO seller in Q1 2022 was Pictet Asset Management (Switzerland), an estimated $776K sold.

Based on aggregated 13F filings for Q1 2022.